menu
    • menu

    Company profile for SEngine Precision Medicine

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Smithfield BioScience transforms bioproducts into trusted, life-saving therapies through safe, reliable U.S.-based manufacturing.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    SWATI - Transforming science into solutions with 60+ years of expertise, global accreditations, and pioneering biotech innovation.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    SEngine Precision Medicine empowers patients and oncologists with more informed treatment options. SEngine's high-throughput technology simultaneously tests more than 200 cancer drugs against a patient's unique tumor organoid outside the body. The results decode the most effective and least toxic treatment options that DNA sequencing alone cannot reveal. The proprietary platform leverages the aggregated, anonymized test result...
    SEngine Precision Medicine empowers patients and oncologists with more informed treatment options. SEngine's high-throughput technology simultaneously tests more than 200 cancer drugs against a patient's unique tumor organoid outside the body. The results decode the most effective and least toxic treatment options that DNA sequencing alone cannot reveal. The proprietary platform leverages the aggregated, anonymized test results to develop new cancer-fighting drugs.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    SEngine Precision MedicineUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    401 Terry Ave N. Seattle, WA, 98109
    Telephone
    Telephone
    (833) 736-4163
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://senginemedicine.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/sengine-precision-medicine/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    Global ChemShow

    Not Confirmed

    envelop Contact Supplier

    Global ChemShow

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    SEngine Precision Medicine Receives New York State CLEP Approval for PARIS Test
    SEngine Precision Medicine Receives New York State CLEP Approval for PARIS Test

    07 Mar 2023

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2023/03/07/2622423/0/en/SEngine-Precision-Medicine-Receives-New-York-State-CLEP-Approval-for-PARIS-Test.html

    GLOBENEWSWIRE
    07 Mar 2023
    Share Share
    SEngine Precision Medicine Announces New Non-Small Cell Lung Cancer Study
    SEngine Precision Medicine Announces New Non-Small Cell Lung Cancer Study

    27 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/27/2523759/0/en/SEngine-Precision-Medicine-Announces-New-Non-Small-Cell-Lung-Cancer-Study-at-Johns-Hopkins-University.html

    GLOBENEWSWIRE
    27 Sep 2022
    Share Share
    SEngine Precision Medicine Partners with Vincere Cancer Center to Access
    SEngine Precision Medicine Partners with Vincere Cancer Center to Access

    07 Sep 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/09/07/2511949/0/en/SEngine-Precision-Medicine-Partners-with-Vincere-Cancer-Center-to-Increase-Access-for-First-Responders-to-Get-Personalized-Cancer-Treatments-via-the-PARIS-Test.html

    GLOBENEWSWIRE
    07 Sep 2022
    Share Share
    SEngine Precision Medicine closes Series A bringing total financing to $19M
    SEngine Precision Medicine closes Series A bringing total financing to $19M

    28 Jul 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/07/28/2487662/0/en/SEngine-Precision-Medicine-closes-Series-A-bringing-total-financing-to-19M-enabling-continued-advancement-of-personalized-cancer-treatments.html

    GLOBENEWSWIRE
    28 Jul 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search